The CEO of the controversial firm says the new service is possible to due its existing technology, plus increased capacity at the Wilsonville facility Earlier this week, the Wilsonville-based biotech ...

The closure, broken by Endpoints News on Thursday after speaking with two former employees, appears to have officially ...

It doesn’t matter how well a drug kills cancer cells if the patient doesn’t stay on treatment. Side effects lead many patients to interrupt dosing of a drug regimen, allowing cancer to advance, said ...

Serán Bioscience, LLC,  in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony ...

Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, ...

Skye Bioscience Inc. (NASDAQ:SKYE) shares gained 5.3% in premarket trading on Monday after the company revealed a ...

A new Bend-based bioscience lab could become operational as early as December of this year, with manufacturing and analytical capabilities coming online in mid-2023. Earlier this month, the ...

Rather than yeast or microalgae, the company is working with oleaginous bacteria—which it claims are more productive.

Niagen Bioscience continues to see improving demand for Tru Niagen, strengthening cash generation, and a debt-free balance ...

The average one-year price target for Lexaria Bioscience (NasdaqCM:LEXX) has been revised to $4.59 / share. This is a decrease of 15.62% from the prior estimate of $5.44 dated December 18, 2025. The ...

Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.

CAMBRIDGE, Mass., July 01, 2025--(BUSINESS WIRE)--Quiver Bioscience ("Quiver"), a discovery technology and therapeutics company advancing programs for treatment of serious central nervous system (CNS) ...